首页> 外文期刊>Drug metabolism and pharmacokinetics. >Evaluation of cytochrome P450-based drug metabolism in hemorrhagic shock rats that were transfused with native and an artificial red blood cell preparation, Hemoglobin-vesicles
【24h】

Evaluation of cytochrome P450-based drug metabolism in hemorrhagic shock rats that were transfused with native and an artificial red blood cell preparation, Hemoglobin-vesicles

机译:用天然和人工红细胞制备血红蛋白 - 囊泡转发出血性休克大鼠细胞色素P450类药物代谢的评价

获取原文
           

摘要

Hemoglobin-vesicles (Hb-V) are being developed as red blood cell (RBC) substitutes. In this study, we report on quantitative and qualitative alterations of hepatic cytochrome P450 (CYPs) and the pharmacokinetics of CYP-metabolizing drugs, with a focus on four CYP isoforms (CYP1A2, CYP2C11, CYP2E1 and CYP3A2), after Hb-V resuscitation from a massive hemorrhage. The results of proteome analysis and western blot data indicate that resuscitation with both Hb-V and packed RBC (PRBC) resulted in a decrease in the protein levels of CYPs. Along with a decrease in the protein expression of CYPs, pharmacokinetic studies showed that the elimination of CYP-metabolizing drugs was prolonged in the Hb-V and PRBC resuscitation groups. It is also noteworthy that the CYP-metabolizing drugs in the Hb-V resuscitation group was retained for a longer period compared to the PRBC resuscitation group, and this is attributed to the CYP isoforms having a lower metabolic activity in the Hb-V resuscitation group than that for the PRBC resuscitation group. These findings suggest that resuscitation with Hb-V after a massive hemorrhage has a slight but not clinically significant effect on drug metabolism via CYPs in the liver due to decreased protein levels and the metabolic activity with respect to the CYPs.
机译:血红蛋白 - 囊泡(HB-V)被开发为红细胞(RBC)替代品。在这项研究中,我们报告了肝细胞色素P450(CYPS)的定量和定性改变和CYP代谢药物的药代动力学,重点在HB-V复苏后,重点关注四种CYP同种型(CYP1A2,CYP2C11,CYP2E1和CYP3A2)。一种巨大的出血。蛋白质组分析和蛋白质印迹数据的结果表明,随着HB-V和填充的RBC(PRBC)的复苏导致CYP的蛋白质水平降低。随着CYP的蛋白质表达的减少,药代动力学研究表明,在HB-V和PRBC复苏组中延长了消除CYP代谢药物。还值得注意的是,与PRBC复苏组相比,HB-V复苏组中的CYP代谢药物保留了较长的时间,这归因于HB-V复苏组中具有较低代谢活性的CYP同种型而不是PRBC复苏组。这些发现表明,由于蛋白质水平降低和关于CYPs的代谢活性,通过肝脏中的CYPs对药物代谢进行轻微但没有临床上显着影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号